Sign in
TerminatedNo phase

Effect of DIRECT Transfer to ANGIOsuite on Functional Outcome in Severe Acute Stroke

Key facts

Who runs it
Central Hospital, Nancy, France
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
120 people enrolled
Started
9 Jul 2020
Ended
3 Apr 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • direct angio-suite admission
  • standard management
Record updated
8 April 2026
Why it stopped
Following the interim analysis, the planned number of staff (208) will not be sufficient to achieve the main objective

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Aged from 18 to 85 years,
  • Rapid neurological examination by the neurologist of the participating centre before randomization,
  • Suffered from acute severe neurological deficit at hospital admission confirmed by neurologist defined as:; Unilateral motor deficit with a total score ≥ 5; Facial palsy: item 4 of NIHSS (score 0 to 2); Arm: item 5 of NIHSS (score 0 to 4); Leg: item 6 of NIHSS (score 0 to 2) AND; Cortical symptom with a total score ≥ 1; Language: item 9 of NIHSS (score 0 to 3); Extinction: item 11 of NIHSS (score 0 to 2)
  • Patients who admitted to hospital within 5 hours after symptom onset
  • Known onset time of symptom
  • Only mothership admissions
  • Fully autonomous patient (pre-stroke mRS ≤2)
  • Availability of the angio-suite and endovascular treatment team at the randomization
  • Person affiliated to or beneficiary of a social security plan

Who cannot take part

  • Severe allergy to iodinated contrast agents,
  • Any conditions that could hamper the 3-month outcome recording
  • Ongoing pregnancy,
  • Breastfeeding,
  • Consent refusal or opposition of the relatives,
  • Individuals under mandatory legal guardianship or unable to consent and whose relatives oppose the research,

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Rationale: Acute large-vessel strokes, requiring endovascular treatment, are currently being managed through radiology department before being transferred to the angiography room. However, patients with severe neurological deficit have demonstrated even greater benefits from recanalization as the symptom onset-to-reperfusion time is shortened to less than 1 hour. Recent pilot study have shown a benefit in reducing management delays with direct admission to the angiography room and subsequently in increasing functional independence at 3 months. Therefore, the aim is to demonstrate the superiority of the direct angio-suite transfer versus the standard management, in terms of 3-month functional independence, in patients strongly suspected of having a severe ischemic stroke related to acute large-vessel occlusion of the anterior circulation, and treated by mechanical thrombectomy ± intravenous thrombolysis.

Read full original descriptionShow less

Methods and Design: The DIRECT ANGIO trial is a (PROBE) randomized, multicenter, controlled, open-label, blinded endpoint clinical trial.

Study Outcomes: The primary outcome is the rate of patients with 3-month functional independence defined as modified Rankin Scale score ≤2 at 3 months.

The 2 groups in the trial

  • Direct angio-suite admissionTreatment being tested

    Upon arrival in angio-suite and after neurological examination with scoring NIHSS and pre stroke mRS, and performing the blood sample, patient undergoes rotational CBCT in order to exclude intracerebral hemorrhage and cerebral angiography to confirm proximal arterial occlusion. Mechanical thrombectomy is then performed as well as intravenous thrombolysis in the absence of contraindications.

  • Standard managementExisting treatment, for comparison

    Arrival is in the MRI/CT-scan room or in the emergency department. Directly after neurological examination and blood sample, patient undergoes imaging and then bridging therapy, mechanical thrombectomy or intravenous thrombolysis alone when indicated.

Results explained

A paper that names this trial, explained in plain words.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of DIRECT Transfer to ANGIOsuite on Functional Outcome in Patient With Severe Acute Stroke Treated With Thrombectomy: the Randomized DIRECT ANGIO Trial
Publications
Record updated
8 April 2026